Centiva Capital, LP Ionis Pharmaceuticals Inc Transaction History

Centiva Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $356,162 - $453,782	8,474 New	8,474 $367,000
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $512,319 - $627,158	13,307 New	13,307 $603,000
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $234,654 - $318,200	7,400 New	7,400 $274,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $1.2 Million - $1.83 Million	-28,932 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $1.16 Million - $1.41 Million	21,596 Added 294.38%	28,932 $1.75 Million
Q3 2019 Nov 13, 2019	BUY	$59.06 - $72.15 $433,264 - $529,292	7,336 New	7,336 $439,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.